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Loss of the RNA-binding protein Bicaudal-C (Bicc1) provokes renal and pancreatic cysts as well as ectopicWnt/-catenin signal-
ing during visceral left-right patterning. Renal cysts are linked to defective silencing of Bicc1 target mRNAs, including adenylate
cyclase 6 (AC6). RNA binding of Bicc1 is mediated by N-terminal KH domains, whereas a C-terminal sterile alpha motif (SAM)
self-polymerizes in vitro and localizes Bicc1 in cytoplasmic foci in vivo. To assess a role for multimerization in silencing, we con-
ducted structure modeling and thenmutated the SAM domain residues which in this model were predicted to polymerize Bicc1
in a left-handed helix. We show that a SAM-SAM interface concentrates Bicc1 in cytoplasmic clusters to specifically localize and
silence boundmRNA. In addition, defective polymerization decreases Bicc1 stability and thus indirectly attenuates inhibition of
Dishevelled 2 in theWnt/-catenin pathway. Importantly, aberrant C-terminal extension of the SAM domain in bpkmutant
Bicc1 phenocopied these defects. We conclude that polymerization is a novel disease-relevant mechanism both to stabilize Bicc1
and to present associated mRNAs in specific silencing platforms.
The asymmetric distribution and localized translation ofmRNAs control the expression of many proteins in a wide
range of cells and tissues. Well-known examples include maternal
determinants of embryo patterning and asymmetric fates in Dro-
sophila oocytes, such as bicoid, oskar (osk), gurken (grk), and nanos
mRNAs. Multiple trans-acting factors associate with these
mRNAs in dynamic ribonucleoprotein (RNP) complexes to or-
chestrate nuclear processing, translational silencing, transport,
cytoskeletal anchoring, and derepression of translation at the final
destination (1). Defects at any of these steps can have dramatic
consequences. In particular, the failure to activate the translation
of osk mRNA in the posterior pole plasm prevents the formation
of abdominal structures and germ cells, whereas precocious osk
mRNA translation in anterior oocytes blocks head formation and
can give rise to a bicaudal phenotype with posterior duplications
(2–6).
Posterior localization and translational regulation of osk
mRNA aremediated by specific cis- and trans-acting elements and
by multiple interacting factors and regulatory proteins (7–9), in-
cluding Bicaudal-C (Bic-C; reviewed in reference 10). Bicaudal-C
comprises three KH domains with characteristic RNA-binding
GXXG signatures, where G represents glycine and one or both
residues X are basic (11, 12). The three KH and two KH-like do-
mains that are distinguished by the absence of GXXG signatures
are linked to a C-terminal sterile alpha motif (SAM) by a long
glycine/serine-rich intervening sequence (see Fig. S1A in the sup-
plemental material). The loss of Bic-C inDrosophila oocytes leads
to the premature derepression of osk translation (13, 14) and ec-
topic anterior localization of grk mRNA (15). A biochemical
screen for direct targets revealed binding of Bic-C to stau mRNA
and to several other transcripts (16). In addition, Bic-C has been
shown to recruit CCR4-NOT deadenylase to attenuate its own
translation (16).
Mutations in mouse and human Bic-C homologs, as well as
knockdown of Xenopus Bic-C, revealed an essential role in renal
tubule morphogenesis (17–19). In jcpk mutant mice, Bicc1 is
truncated before the first KH domain, whereas a GC insertion in
bpk mutant mice changes the reading frame within the last exon
so that 21 amino acids at the C terminus are replaced by 149
aberrant residues (17) (see Fig. S1B in the supplementalmaterial).
Bicc1jcpk/jcpkmutants develop renal cysts along the entire nephron,
combined with dilated pancreatic and liver bile ducts that are
reminiscent of autosomal dominant polycystic kidney disease
(ADPKD). Unlike homozygotes, which die soon after birth,
heterozygotes develop glomerulocystic disease in 25% of the cases
after ageing (20). In contrast, bpk mutants are a noncongenital
model of autosomal recessive polycystic kidney disease (ARPKD),
with renal cysts arising first in proximal tubules and later in col-
lecting ducts (21). Compared to the time of cyst formation in jcpk
mutants, cyst formation is delayed in bpkmutants, likely because
bpk affects only one of two alternatively spliced transcripts (17,
22). ADPKD is caused by mutations in the PKD1 or PKD2 gene,
whereas ARPKD results from defects in PKHD1. The correspond-
ing proteins, polycystin-1, polycystin-2, and fibrocystin, associate
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with each other and regulate calcium flux in response to mechan-
ical stimulation by fluid flow (23, 24). In embryonic mouse kid-
neys, Pkd1 enhances the expression of Bicc1, which in turn in-
creases the levels of Pkd2 mRNA, indicating that Bicc1 acts both
downstream and upstream of polycystins (25, 26).
Recent functional analysis identified adenylate cyclase 6 (AC6)
and protein kinase inhibitor (PKI)mRNAs to be the first direct
targets of mammalian Bicc1 (27). PKI inhibits protein kinase A
(PKA), whereas AC6 stimulates it by synthesizing cyclic AMP
(cAMP), suggesting a dynamic role for Bicc1 in regulating cAMP/
PKA signaling. Importantly, cAMP and AC6 promote cystic
growth in Pkd1 mutant mice and in ADPKD patients (28–30).
Bicc1 mutant mice also share other key features with human
ADPKD, including impaired apical-basal sorting of the epidermal
growth factor receptor; hyperactivation of its ligand, transforming
growth factor ; and elevated mTOR signaling (31–34). In addi-
tion, Bicc1 is needed during development for the alignment of
motile node cilia by planar cell polarity (PCP) signals that govern
visceral left-right patterning (35, 36). Deregulation of PCP or ca-
nonical Wnt signaling can also trigger renal cysts (23). Together,
these observations highlight the relevance of Bicc1 mutants as a
disease model and the importance of elucidating the molecular
mechanisms that regulate Bicc1 activities at the crossroads ofmul-
tiple signaling pathways.
Repression of AC6 and PKI mRNAs by Bicc1 depends on
specific regions in their proximal 3= untranslated regions
(UTRs) and on cognate microRNAs (miRNAs) (27). While
Bicc1 binds these RNAs independently of the SAM domain,
deletion of the SAM domain blocks their loading into miRNA-
induced silencing complexes (miRISCs) with Argonaute 2
(Ago-2) (27). In addition, the SAM domain increases the po-
tential of Bicc1 to inhibit the Wnt signaling component Di-
shevelled 2 (Dvl2) independently of KH domains in TOPflash
reporter assays, possibly by localizing Bicc1 in a network of
cytoplasmic foci that seem to interact with Dvl2 foci (35).
However, to our knowledge, a role for Bicc1 in localizing target
mRNAs has not been evaluated.
Novel mechanistic insights into mRNA silencing may come
from structure-function analysis of the Bicc1 SAM domain. SAM
domains are found in numerous regulatory proteins and in some
instances mediate the formation of homo- or heterooligomers
(37–39). The crystal structure of the SAM domain of the tran-
scriptional repressor TEL established that self-association in a
head-to-tail configuration via the so-called midloop (ML) and
end helix (EH) surfaces can give rise to a helical polymer (40, 41).
Since a green fluorescent protein (GFP) fusion of the human
BICC1 SAM domain can polymerize in vitro (42), here we asked
whether self-association controls the localization or function of
full-length Bicc1. To address this question, wemodeled the three-
dimensional (3D) structure of the mouse Bicc1 SAM domain and
designed point mutations to disrupt a potential SAM-SAM inter-
face. We show that such mutations inhibit polymerization of full-
length Bicc1 and its cytoplasmic clustering. Furthermore, we re-
port that polymerization-competent Bicc1 recruits an associated
AC6-3= UTR reporter mRNA to cytoplasmic foci and that the
SAM domain promotes mRNA silencing by mediating Bicc1 po-
lymerization. bpk mutant Bicc1 (Bicc1bpk), which is associated
with an ARPKD-like disease, phenocopied these defects, indicat-
ing that SAM polymerization is likely essential for Bicc1 functions
in vivo.
MATERIALS AND METHODS
Plasmids, cloning, and mutagenesis. The luciferase reporter plasmids
pCS::AC6-3=UTRprox and pCS::PKI-3=UTRprox have been de-
scribed previously (27). To construct the AC6-27MS2 reporter plasmid,
24 repeats of a motif that binds the bacteriophage MS2 coat protein were
amplified by PCR from pCR4-24MS2SL-stable (catalog number 31865;
Addgene) and added to 3 existing MS2 sites in plasmid pCS::AC6-
3=UTRprox by insertion into a unique PstI site. To subclone the mutant
Bicc1 cDNAs encoding the mutation in mutant A (mutA) to mutF and
bpk, the plasmid pCMV-SPORT6::HA-Bicc1 (35) was modified by intro-
ducing a silent BglII site upstream of the SAM-coding sequence. Mutant
cDNA fragments were then cloned between this engineered BglII site and
a unique XbaI site. Mutant cDNA fragments encoding the mutations in
mutA to mutF were generated by overlap extension PCR. The plasmids
carrying Bicc1bpk and the splice variant B of wild-type (WT) Bicc1 were
obtained by introducing a synthetic cDNA (Proteogenix) into the pCMV-
SPORT6::HA-Bicc1 vector. The sequences of all mutated expression vec-
tors were verified by Sanger sequencing. The plasmids pTOPFLASH (43),
pCDNA3.1::mDvl2 (44), pDCP1a-GFP (45), and pGEX-1T::SAM (27)
were previously described.
Recombinant GST-SAM and custom anti-Bicc1 antibody. The
pGEX-1T::SAMplasmid was used to produce the recombinant glutathi-
one S-transferase (GST)–SAM protein in the Escherichia coli BL21 strain
(Novagen) as described previously (27). The GST-SAM protein was pu-
rified from cell extracts under native conditions, using glutathione-Sep-
harose 4B, as recommended by the manufacturer (GE Healthcare). Puri-
fication was carried out in a buffer consisting of 50 mM Tris-HCl, pH 8,
200 mM NaCl, 1 mM dithiothreitol (DTT). When necessary, 20 mM
glutathione was added for elution. A custom polyclonal Bicaudal-C anti-
body against GST-SAM was raised by Proteogenix (Oberhausbergen,
France) in rabbit by development of an antibody against the mouse Bicc1
SAM domain (residues 870 to 984) fused to an N-terminal His tag. The
antibody was affinity purified and tested for its activity against the antigen
by enzyme-linked immunosorbent assay.
Bicc1 mutant mice. Mice heterozygous for a targeted null allele of
Bicc1 were maintained on a C57BL/6 mouse genetic background in indi-
vidually ventilated cages at the Ecole Polytechnique Fédérale de Lausanne
(EPFL) animal facility as described previously (35).Mice homozygous for
the hypomorphic bpk allele of Bicc1 have been described previously (17,
21, 34). All animal experiments were approved by the Veterinary Service
of the Swiss canton of Vaud or by the Institutional Animal Care and Use
Committee and adhered to the guidelines in theGuide for the Care andUse
of Laboratory Animals (46).
Cell culture and transfections. HEK293T and COS-1 cells were cul-
tured in Dulbecco modified Eagle medium (Sigma) supplemented with
10% fetal bovine serum (FBS; Sigma), glutamine (1%; Invitrogen), and
gentamicin (1%; Invitrogen). Plasmids were transfected using the jetPEI
transfection reagent (Polyplus Transfection) according to the manufac-
turer’s instructions. Scrambled and Lsm1 small interfering RNAs were
transfected 24 h prior to plasmid transfection using the INTERFERin
transfection reagent (Polyplus Transfection).
Indirect immunofluorescence analysis and histological stainings.
For immunostaining, COS-1 cells were transfected with hemagglutinin
(HA)-tagged Bicc1 (HA-Bicc1) and GFP-Dcp1a (1 g DNA each) in
6-well plates. After 24 h, the cells were split and grown on sterile coverslips
in 24-well plates. At 48 h after transfection, the cells were fixed for 10 min
at20°C inmethanol and washed with phosphate-buffered saline (PBS).
The coverslips were incubated for 1 h at room temperature for blocking in
PBS containing 1%bovine serum albumin (BSA) and then for 2 h at room
temperature in blocking buffer containing the anti-HA primary antibody
(1/500, rabbit; Sigma). After washes in PBS, the Alexa Fluor 568-conju-
gated anti-rabbit secondary antibody was added, and the mixture was
incubated in blocking buffer for 1 h at room temperature in the presence
of DAPI (4=,6-diamidino-2-phenylindole; 1/10,000). Pictures were ac-
quired on a Zeiss LSM700 confocal microscope.
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For cryosectioning, organs were collected from Bicc1 mutants and
control littermates at postnatal day 2, fixed for 4 h in 4% paraformalde-
hyde, soaked in 15% sucrose overnight at 4°C, and embedded in opti-
mum-cutting-temperature (OCT) compound on isopentane. Sections (8
m) were permeabilized for 10 min at room temperature with PBS, 0.2%
TritonX-100 and then incubated for 2 h at room temperature for blocking
in PBS containing 1% BSA. An additional blocking step using a strepta-
vidin-biotin blocking kit (catalog number SP-2002; Vector Laboratories)
was added specifically for biotinylated Lotus tetragonolobus lectin (LTL)
detection. Primary antibodies anti-Bicc1 SAM (1/300, rabbit) (27), anti-
Dcp1a (1/100, mouse; Abnova), anti-CK19 (1/50, human; Santa Cruz
Biotechnology), and biotinylated LTL (1/200; Vector Laboratories) were
added and incubated overnight at 4°C. Bicc1 antibody was preabsorbed
with embryo powder (1/100) prior to incubation. After washing in PBS–
0.1% Triton X-100, secondary antibodies (anti-rabbit antibody–Alexa
Fluor 488, anti-mouse antibody–Alexa Fluor 647, anti-human antibody–
Alexa Fluor 568, or streptavidin-Alexa Fluor 568) were incubated in PBS–
0.1% Triton X-100 for 1 h at room temperature. Nuclei were stained with
DAPI (1/10,000) during the final washes. Stained sections were mounted
in DABCO (1,4-diazabicyclo[2.2.2]octane). Images were acquired on a
Zeiss LSM700 confocal microscope.
Molecular modeling andMD simulation. The X-ray structure of the
diacylglycerol kinase 1 (DGK1) SAM dimer (PDB accession number
3BQ7) (47)was identifiedwith tools from the SWISS-MODELwork space
(48). The software MODELLER (v9.5) (49) was used to align the Bicc1
and DGK1 sequences and to construct 100 models of the Bicc1 SAM
domain dimer. The best model, according to the discrete optimized pro-
tein energy (DOPE) (50) score, was set up for molecular dynamics (MD)
simulation with a GROMACS (v4.5) simulation tool kit (51). The protein
was simulated in water and subjected to energy minimization with the
steepest-descent method (52) and state-of-the-art equilibration. TheMD
simulation was then carried out using GROMACS (v4.5) software and the
CHARMM27 force field (53). The system was simulated for 10 ns in the
isobaric-isothermal ensemble, with the pressure being maintained at 1
atm and the temperature being maintained at 300 K. Final models were
rendered in the PyMOL program (Schrödinger).
Electron microscopy. Twenty microliters of protein sample at 0.5
g/l was deposited on a carbon-Formvar grid (TedPella Inc.), incubated
for 2 min, and blotted dry. The grid was then covered with 20 l of 2%
uranyl acetate, incubated for 2 min, and blotted dry. Samples were visu-
alized on a JEOL JEM-2200FS transmission electron microscope.
Immunoprecipitation and RT-PCR analyses. To monitor protein-
RNA interactions, immunoprecipitationswere conductedwithHEK293T
cells transfected in 10-cm dishes (for Bicc1 WT, 1 g DNA was used; for
Bicc1 mutD, mutant Bicc1 lacking SAM [Bicc1	SAM], and the Bicc1 bpk
mutant, 2gDNAwas used). At 36 h after transfection, cells were washed
with PBS and resuspended in extraction buffer, consisting of 20mMTris-
HCl, pH 7.4, 2.5 mM MgCl2, 100 mM NaCl, 5% glycerol, 1 mM DTT,
0.05% NP-40, RNasin (Promega), and protease inhibitors (Roche). After
a brief sonication and centrifugation at 10,000 g for 10 min, the super-
natants were incubated for 2 h at 4°C with anti-HA beads (Sigma) on a
wheel. After five washes of 5 min each in washing buffer, consisting of 20
mMTris-HCl, pH7.4, 2mMMgCl2, 200mMNaCl, 1mMDTT, and 0.1%
NP-40, RNAswere isolated by phenol-chloroform extraction, followed by
ethanol precipitation and RQ1 DNase (Promega) treatment. Reverse
transcription-PCR (RT-PCR) analyses were carried out using SuperScript
II reverse transcriptase (Life Technologies) according to the manufactur-
er’s recommendations. The reverse transcriptionwas performed using the
following primer: CAGTGCAGGGTCCGAGGTATTCGGCCTCTGCGC
TTTCTC. The PCR was carried out using the forward primer GAAGAT
CGGGTTGAACATGGGTCC and the reverse primer CAGTGCAGGGT
CCGAGGTATTC.
GST pulldown assays. To monitor interactions between GST-SAM
and HA-Bicc1, HEK293T cells were transfected in 6-well plate dishes (for
the Bicc1 WT, mutA, mutB, and mutF, 1 g DNA was used; for Bicc1
mutC, mutD, and mutE and the 	SAMmutants, 2 g DNA was used) or
10-cm dishes (for Bicc1bpk, 8 g DNA was used). Cell extracts were pre-
pared as mentioned above for the immunoprecipitation assays. Superna-
tants were incubated for 2 h at 4°C with glutathione-Sepharose 4B beads
saturated with GST-SAM or GST for the negative control. After washing
as described above, the beads were resuspended in Laemmli buffer, frac-
tionated on SDS-polyacrylamide gels, and analyzed by Western blotting.
Anti-HA antibodies (1/1,000, rabbit; Sigma) were used for the detection
of HA-Bicc1. The retention of the GST-SAM bait was monitored directly
by Coomassie staining.
Sucrose gradient fractionation assays. HEK293T cells were trans-
fected in 10-cm dishes, using 3 plates per condition (2 g DNA/plate).
Cell extracts were prepared as mentioned above for the immunoprecipi-
tation assays. Continuous 15 to 60% sucrose gradients were prepared
manually by layering and passive diffusion of sucrose solutions prepared
in buffer consisting of 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.05%
NP-40. Identical volumes of cell extracts were fractionated at 4°C by cen-
trifugation at 100,000 g for 3 h. Fractionswere recoveredmanually from
the top, fractionated on SDS-polyacrylamide gels, and analyzed by West-
ern blotting. Anti-HA antibodies (1/1,000, rabbit; Sigma) were used for
the detection of HA-Bicc1. Anti-
-tubulin (1/2,000, mouse; Sigma) and
anti-ribosomal protein S6 (anti-RPS6; 1/1,000, mouse; Cell Signaling)
antibodies were used to detect, respectively, 
-tubulin and RPS6 proteins,
which were used as internal controls.
Protein half-life measurements. HEK293T cells were transfected in
6-well plate dishes (1 g DNA). At 24 h after transfection, cycloheximide
(CHX; Sigma) was added at a final concentration of 100g/ml. Cells were
collected before treatment (0 h) and 8, 24, 32, 48, and 56 h after cyclohex-
imide addition. Cell extracts were prepared as mentioned above for im-
munoprecipitation assays. Anti-HA antibodies (1/1,000, rabbit; Sigma)
were used for the detection of HA-Bicc1, and anti-
-tubulin antibodies
(1/2,000, mouse; Sigma) were used for normalization.
Luciferase assays.HEK293T cells were plated in 24-well plates. Af-
ter 12 h, quadruplicate samples were transfected with the plasmids
indicated below (a 1 dose was 0.1g/well) and with a lacZ expression
vector (0.05 g/well) using jetPEI (Polyplus Transfection). At 36 h
after transfection, cells extracts were prepared in buffer consisting of
25 mM Tris-phosphate, pH 7.8, 2 mM DTT, 2 mM CDTA (1,2-di-
aminocyclohexanetetraacetic acid), 10% glycerol, 0.5% Triton X-100.
The measurements of luciferase expression levels were carried out using
20-fold-diluted extracts, and luminescent counts were normalized to
-galactosidase activity. Results represent mean values from at least 3
independent experiments performed in quadruplicate, and error bars
show the standard errors of themeans (SEMs). Student’s t test was used to
calculate P values.
RESULTS
Cytoplasmic clustering of Bicc1 in mouse kidney and liver epi-
thelial cells. Bicc1-deficient mice are born with cysts in their kid-
neys and pancreas and dilated liver bile ducts (25, 27, 54). Con-
cordant with a function in renalmorphogenesis, the Bicc1 protein
is expressed in the newborn mouse kidney cortex (25, 27). How-
ever, the distribution of Bicc1 in this or other tissues has not been
resolved at a subcellular level. To address this, we stained frozen
sections of postnatal kidneys and livers using a novel custom anti-
Bicc1 antibody that specifically reacts with the tissues of wild-type
but not Bicc1/mice (see Fig. S2 in the supplemental material).
Lotus tetragonolobus lectin (LTL), which is expressed in proximal
tubules, was used to mark cortical renal structures, whereas the
cholangiocytes of liver bile ducts were marked by cytokeratin-19
(CK19). High-resolution imaging revealed a nonhomogeneous
distribution of endogenous Bicc1 in clusters of cytoplasmic
puncta both in renal proximal tubule cells and in cholangiocytes
(Fig. 1). The volumes of these puncta varied from 0.05 to 0.6m3,
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similar to those of cytoplasmic foci detected by anti-HA staining
of tagged Bicc1 in transfected HEK293T cells, although the latter
were larger, on average, possibly due to overexpression rather than
alternative fixation or the use of anti-HA antibody instead of anti-
SAM antibody (see Fig. S3 in the supplemental material). These
data show that Bicc1 clusters in cytoplasmic puncta and that this
pattern is not restricted to one tissue but could be a general feature
of Bicc1.
Cytoplasmic Bicc1 foci contain target mRNA. Bicc1 cluster-
ing may influence the localization of associated target mRNAs or
affect RNA binding, or both. To distinguish between these possi-
bilities, we monitored the localization of a reporter mRNA con-
taining the Bicc1 binding region of the AC6 3= UTR (27) and 27
repeats of a motif that binds the bacteriophage MS2 coat protein
(theMS227motif) (55). Coimmunoprecipitation and luciferase
assays with HA-Bicc1 from extracts of transfected HEK293T cells
showed that Bicc1 specifically binds this reporter mRNA and in-
hibits its expression, as expected (Fig. 2A to C). To assess whether
Bicc1 influences mRNA localization, we cotransfected a fusion
protein ofMS2with nuclear yellow fluorescent protein (YFP) into
COS-1 cells. Like HEK293T cells, COS-1 cells show no endoge-
nous Bicc1 expression but are more adhesive, have a larger cyto-
plasm, and, thus, aremore amenable for imaging.MS2-YFPwith-
out Luc-AC6-MS227 reportermRNA localized to nuclei both in
the presence and in the absence of HA-Bicc1 (Fig. 2D, rows 1 and
2). However, when coexpressed with Luc-AC6-MS227 and
without Bicc1, MS2-YFP accumulated diffusely throughout the
cytoplasm, confirming that MS2-YFP was exported from the nu-
cleus together with the reporter mRNA (Fig. 2D, row 3). Interest-
ingly, the combined expression of the Luc-AC6-MS227 reporter
with HA-Bicc1 led to the concentration of MS2-YFP in cytoplas-
mic Bicc1 puncta, with 89% 8% of the cytoplasmic YFP signal
colocalizing with Bicc1 foci (Fig. 2D, row 4). We therefore asked
whether the Luc-AC6-MS227 reporter also enters cytoplasmic
foci in the mIMCD3 mouse inner medullary collecting duct cell
line that expresses endogenous Bicc1 (56). Transfection of the
reporter RNA was sufficient to translocate the MS2-YFP fusion
protein from the nucleus to cytoplasmic Bicc1-stained foci inde-
pendently of exogenous Bicc1 (see Fig. S4A in the supplemental
material). Even though we could not sufficiently deplete endoge-
nous Bicc1 foci by RNA interference tomore conclusively validate
their function (not shown), their colocalization with reporter
RNA strongly corroborates our conclusion that target mRNAs are
recruited to endogenous Bicc1 in cytoplasmic clusters.
3D model of Bicc1 SAM-SAM interface. Bicc1 is localized in
cytoplasmic foci by its SAM domain independently of the RNA-
binding KH domains (35). Certain SAM domains can form
dimers or polymeric structures (57), and a polymer of the human
Bicc1 SAM domain fused to GFP has been observed in vitro by
electron microscopy (EM) (42). To test whether SAM polymer-
ization is responsible for Bicc1 clustering, we searched for muta-
tions that specifically disrupt polymerization. Since structure data
for Bicc1 or its SAM domain are currently unavailable, mutations
were designed on the basis of homology modeling, where the
known structure of a related protein serves as a template. Among
the available templates, we selected the SAM domain dimer of the
diacylglycerol kinase 1 (DGK1) E35G (PDB accession number
3BQ7) because it shares the highest sequence similarity (54%) and
identity (31%) with the Bicc1 SAM domain (Fig. 3A) and can
form head-to-tail polymers (47). A model of dimeric Bicc1 SAM
obtained after energy minimization revealed a common globular
fold of five  helices, with two SAM subunits being docked to one
another at characteristic ML and EH surfaces (Fig. 3B) (40). Res-
idues involved in the dimerization of the DGK1 SAM are con-
served or replaced by similar amino acids in the Bicc1 SAM do-
main (highlighted in Fig. 3A). At the Bicc1 SAM-SAM interface, 4
negatively charged amino acids on the ML surface (Glu900,
Asp902, Asp913, Glu916) and 5 positively charged amino acids
from the EH surface (Lys891, Lys915, Arg925, Arg926, Lys927)
form strongly polarized electrostatic networks in two independent
regions of contact (Fig. 3C and D; see also Fig. S5 in the supple-
mentalmaterial). In addition, residue Phe922 from the EH surface
FIG 1 Bicc1 protein forms cytoplasmic clusters in mouse kidney cells and bile duct cholangiocytes. (A) Frozen sections of WT mouse kidney labeled with
anti-Bicc1 antibodies and with the proximal tubule marker LTL on postnatal day 4. (B) Frozen sections of liver of aWTmouse obtained postnatally labeled with
anti-Bicc1 and anti-CK19 antibodies. CK19 is an intermediate filament protein of epithelial tissues. The boxed areas in the left panels are magnified in the three
panels to the right. Bars, 10 m (large views) and 2 m (magnified views).
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reaches into a hydrophobic pocket of the ML surface comprising
Phe896, Ile901, Leu909, and Leu917 (Fig. 3E).
To assess the stability of this complex, we performed a molec-
ular dynamics (MD) simulation in water. For 10 ns, the backbone
root mean square deviation (RMSD) was 2.05 Å. Electrostatic and
hydrophobic interactions and minimal root mean square fluctu-
ation (RMSF) of most of the residues persisted, except at the un-
constrainedNH2 andCOOHextremities, indicating that the com-
plex remained stable (see Fig. S6A and B in the supplemental
material). The number of intermolecular H bonds increased dur-
ing the dynamic from 5 to an average of 8.9 H bonds per time
frame, indicating significant stabilization (see Fig. S6C in the sup-
plemental material). This result validates the confidence of our
dimeric model. To directly confirm the potential to self-polymer-
ize, we imaged a GST fusion of recombinant mouse Bicc1 SAM.
Negative-staining EM of GST-Bicc1 SAM revealed ovoid struc-
tures that were, on average, 28.8 3.9 nm long and 22.8 3.4 nm
wide (see Fig. S7 in the supplemental material). This size resem-
bles that of human Bicc1 SAM fused to enhanced GFP (EGFP)
(42), corresponds to approximately 40 units of the GST-SAM fu-
sion protein, and, therefore, likely represents SAM polymers.
Overall, our results confirm that the Bicc1 SAM interacts with
itself in higher-order structures large enough to be detected in
vitro.
To obtain a 3D model of a Bicc1 SAM domain polymer, we
docked multiple dimers to each other via their EH and ML sur-
faces (Fig. 3F). Polymerization of an arbitrary number of SAM
units in silico formed a left-handed helix with a diameter of 65 Å
and a pitch of 44 Å encompassing 6 SAM units. As observed in
related SAM polymers (40), the N and C termini were positioned
peripherally, indicating that a central SAM polymer in full-length
Bicc1 is surrounded by the N-terminal KH domains, with the
intervening regions forming a linker to the SAM, and by the short
C termini (see Fig. S1A in the supplemental material). To evaluate
FIG 2 Bicc1 concentrates an associated reporter mRNA in cytoplasmic foci. (A) Principle of theMS2-YFP colocalization assay. The 3= extremity of the Luc-AC6
reporter mRNAwas fused to 27MS2 hairpins, which constitute multiple binding sites for theMS2 protein fused to YFP. CDS, coding sequence; prox, proximal.
(B) RNA coimmunoprecipitation. The Luc-AC6-MS227 reporter mRNA was expressed in HEK293T cells together with HA-Bicc1 or empty vector. After HA
immunoprecipitation (IP), the various fractions were analyzed by Western blotting and by RT-PCR. Five percent of the total extract was used as the input. The
-actin mRNAwas used as a negative control for the RT-PCR. HA-Bicc1 lacking all KH and KH-like domains (	KH) was used as an additional negative control
for RNA-binding specificity. (C) Cotransfection of the fluorescent YFP-MS2 fusion protein does not affect the silencing of the Luc-AC6-MS227 reporter by
HA-Bicc1.-Galactosidase was used as a control for normalization, and the data represent the percent expression relative to that of amock-treated control. Error
bars showSEMs. *,P 0.005. (D) Localization by indirect immunofluorescence staining of the Luc-AC6-MS227 reportermRNAandHA-Bicc1 inCOS-1 cells.
The MS2-tagged mRNA was detected by the relocalization of fluorescent MS2-YFP fusion protein, which binds the MS2 RNA hairpins. Bars, 5 m.
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FIG 3 Molecular modeling of a Bicc1 SAM polymer. (A) ClustalW alignment of mouse (Mus musculus) Bicc1 (mBicc1) and human (Homo sapiens) DGK1
(hDGK1) SAM domains. The X-ray structure of dimeric DGK1 SAM (PDB accession number 3BQ7) served as the template to model the Bicc1 SAM dimer.
The two SAM domains share 31% identity and 54% similarity. Predicted  helices are framed. Residues of the ML surface (red), residues from the EH surface
(blue), and hydrophobic residues (underlined) are highlighted. Dark and light gray shading corresponds to identical and similar amino acids, respectively,
between Bicc1 and the DGK1 template. (B) Dimeric Bicc1 SAMmodel obtained using MODELLER (v9.5) software. The  helix numbers and the side chains
of the residues involved in the interface are displayed. (C to E)Magnified views of themain interacting patches in the predicted Bicc1 SAMdimer interface. Acidic
and basic residues are displayed in red and blue, respectively. (F)Model of a Bicc1 SAMpolymer of 24 units in surface representation. TheNH2 terminus and the
COOH terminus of each SAM domain are displayed in green and purple, respectively. (G) Model of the Bicc1 KH domain region in surface representation.
Models for individual KH domains were obtained by homology modeling using the SWISS-MODEL work space (48) and templates consisting of the structures
with PDB accession numbers 1VIG (KH1), 2CTM (KH2), 1WVN (KH3), and 3N89 (KHL1 and -2). Individual KH domains were then superimposed with their
homologous domain in the X-ray structure of ceGLD-3 KH domains (PDB accession number 3N89) (58). The KH domains harboring the GXXG signatures for
RNA binding are highlighted in color. Their putative RNA-binding surfaces are darkened, and the identity of their GXXG signature sequence is given in
parentheses. The KH-like domains (KHL1 and -2) are displayed in gray. (H) Diagram of a transversal section through a polymer of full-length Bicc1. The SAM
polymer is located at the center and displays other Bicc1 domains at its periphery. A schematic representation was used for the other domains. C-ter domain,
C-terminal domain. (I) Diagram in longitudinal view of Bicc1 KH domains distributed along the surface of the central SAM polymer.
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the potential impact of SAM polymerization on RNA binding, we
also modeled the structures of the Bicc1 KH and KHL domains
using the Caenorhabditis elegans GLD-3 (ceGLD-3) X-ray struc-
ture as a template (58) (Fig. 3G). We found that all three RNA-
binding pockets are predicted to reside on the same surface of a
large globular domain. For optimal solvent exposure and access to
RNA, the KH domains of polymeric full-length Bicc1 would thus
have to reside around and peripheral to the central helix organized
by the SAM domain (Fig. 3H and I), consistent with their N-ter-
minal positioning relative to the SAM domain (Fig. 3F). Each
helical turn might thus present as many as 25 KH domains at the
surface of the macromolecular assembly within a distance of only
44 Å. While the exact configuration of such a multimer awaits
experimental validation, we note that the regulation of its length
and helical pitch by SAM polymerization thus likely determines
the number of RNA-binding sites as well as their spacing along the
longitudinal axis (Fig. 3I).
Identification of polymerization-defective Bicc1 mutants.
To test the predictive power of our structural model of dimeric
Bicc1 SAM, we individually replaced six surface-exposed patches
of electrostatic amino acids within or outside the SAM-SAM in-
terface by alanines (Fig. 4A). Four of these groups of mutations
(those in mutB, mutC, mutD, and mutE) should affect intermo-
lecular H bonds, while two others (those inmutA andmutF) were
deliberately introduced outside the predicted dimerization inter-
face (Fig. 4B toD). To screen for polymerization defects, we trans-
fected HA-tagged Bicc1 mutants A to F into HEK293T cells and
assessed their retention on glutathione-Sepharose beads coated
with recombinant GST-SAM fusion protein as a bait. We found
that wild-type HA-Bicc1 efficiently bound to GST-SAM-coated
beads but not to beads coated with GST alone (Fig. 4E). In con-
trast, the Bicc1 mutant lacking SAM (HA-Bicc1	SAM) failed to
bind GST-SAM beads, suggesting that GST-SAM specifically in-
teracts with the SAM domain of full-length Bicc1. Moreover, a
comparison with HA-Bicc1 mutants showed that while the muta-
tions inmutants C, D, and E abolished the SAM-SAM interaction,
the mutations in mutants A and F did not, a result that concurs
with that of our structure model. The mutation in mutant B ex-
hibited an intermediate effect. The mutation in mutant B affected
three amino acids at the periphery of the EH surface, and only one
of them (K891) is predicted to contribute to the SAM-SAM inter-
action (Fig. 3C). According to theoretical predictions, this electro-
static patch is involved in only 1.1 intermolecular H bonds, on
average, explainingwhy itsmutation is insufficient to fully disrupt
dimerization (Fig. 4D). Altogether, these results strongly corrob-
orate our structure model and provide new tools to specifically
probe the consequences of the loss of SAM-SAM interactions in
vivo.
Polymerization governs Bicc1 clustering and localizes asso-
ciated mRNA in cytoplasmic puncta. Among our panel of Bicc1
mutations, the mutation in mutant D disrupted the largest num-
ber of intermolecular H bonds at the SAM-SAM interface (Fig. 4C
and D). To distinguish whether this interface mediates Bicc1
dimerization or the formation of higher-order assemblies, we
compared the sizes of wild-type Bicc1 andmutantD in transfected
HEK293T cells by sucrose gradient fractionation. Analysis of poly-
mericHA-Bicc1 complexes inHEK293T cells revealed a broad size
distribution, with wild-type HA-Bicc1 extending beyond the frac-
tionsmarked by ribosomal protein S6 (RPS6) (59), indicating that
wild-type Bicc1 congregates in molecular assemblies larger than
ribosomes (Fig. 5A). A similar distribution was observed for en-
dogenous Bicc1 in extracts of mIMCD3 cells (see Fig. S4B in the
supplementalmaterial). In contrast,HA-Bicc1mutantDwas con-
centrated in fractions with significantly lower molecular weights
in three independent experiments. These data suggest that at least
the largest Bicc1 assemblies in such cell extracts likely depend on
SAM polymerization. However, despite this marked shift to low-
er-molecular-weight fractions, HA-Bicc1 mutD levels in the first
three fractions did not increase, suggesting that Bicc1 likely fails to
stably accumulate as a free monomer.
To assess the impact of polymerization on Bicc1 function, we
tested whether Bicc1 mutant D forms cytoplasmic puncta. As de-
scribed previously, immunostaining of COS-1 cells and recon-
struction of 3D surfaces detected HA-Bicc1 in a dense network of
corpuscles outside and around P-bodies marked by GFP-Dcp1a
(35). In contrast, Bicc1mutD localizedmore diffusely throughout
the cytoplasm, similar to the findings for Bicc1	SAM (Fig. 5B and
C). Importantly, mutant D also failed to localize the Luc-AC6-
MS227 reporter in cytoplasmic foci, even though mRNA bind-
ing was still detected (Fig. 5C; see also Fig. S8 in the supplemental
material). Taken together, these results suggest that both Bicc1
and associated mRNAs are concentrated in cytoplasmic foci by
specific residues in the SAMdomain thatmediate polymerization.
SAM polymerization is essential for Bicc1 stabilization and
to silencemRNAs but not to inhibit theWnt pathway. Since the
Bicc1 mutant D apparently did not freely accumulate as a mono-
mer in density fractionation gradients, we asked whether polym-
erization influences the protein half-life. Translation inhibition by
cycloheximide (CHX) followed by a time course analysis by im-
munoblotting showed that wild-type HA-Bicc1 remained stable
over the entire chase period (56 h). In contrast, the half-lives of the
HA-Bicc1mutD andBicc1	SAMproteins were reduced to 34 and
29 h, respectively (Fig. 6A), suggesting that SAM polymerization
increases Bicc1 stability. Therefore, in all subsequent assays eval-
uating their functions, we doubled the dose of transfected DNA
for Bicc1 mutants in order to reach expression levels comparable
to those of wild-type HA-Bicc1 (Fig. 6B). In particular, to deter-
minewhether polymerization is necessary formRNA silencing,we
compared the potential of wild-type HA-Bicc1 and mutant D to
silence the 3= UTR sequences of AC6 and PKI mRNAs in lucif-
erase reporter assays. HA-Bicc1 significantly repressed the expres-
sion of these luciferase reporters, as described previously (27). In
contrast, both HA-Bicc1	SAM and HA-Bicc1 mutD failed to re-
press these targets even at an elevated dosage (Fig. 6C and D),
indicating that the silencing activity of Bicc1 directly depends on
SAM polymerization.
Previously, we have shown that Bicc1 can also block the induc-
tion of the TOPflash reporter of canonical Wnt signaling at the
level of Dishevelled 2. This inhibition of Dishevelled signaling is
independent of the mRNA-binding KH domains but is potenti-
ated by the Bicc1 SAM domain (35). To distinguish whether inhi-
bition of Dishevelled 2 activity directly or indirectly depends on
Bicc1 polymerization, we cotransfected wild-type or mutant HA-
Bicc1 with TOPflash and a vector expressing Dvl2. As described
previously (35), HA-Bicc1	SAM inhibited the induction of
TOPflash by Dvl2 less efficiently than wild-type Bicc1. Interest-
ingly, this difference disappeared when the dosage of either HA-
Bicc1	SAM or mutant D was doubled to reach the level of wild-
type HA-Bicc1 expression (Fig. 6B and E), suggesting that SAM
domain polymerization is not essential for Wnt signal inhibition.
Role of Bicc1 SAM Domain Polymerization
October 2015 Volume 35 Number 19 mcb.asm.org 3345Molecular and Cellular Biology
Inhibition of SAMpolymerization andBicc1 function by the
bpkmutation.Ourmodel of the SAMdomain raised the possibil-
ity that elongation of the C terminus in the Bicc1 bpk mutant
inhibits a polymeric SAM helix by overcrowding the surrounding
space (see Fig. S1B in the supplemental material). To test this
hypothesis, we cloned the bpkmutant in amammalian expression
vector. Similar to our engineered mutant D, the bpk mutant dis-
played a drastically reduced half-life compared to that ofwild-type
HA-Bicc1 (Fig. 6A and B). We therefore used pulldown assays to
evaluate whether the bpkmutation also inhibits SAM-SAM inter-
actions. To compensate for reduced protein stability, the HA-
Bicc1 bpk mutant expression vector was transfected in large ex-
cess. Nevertheless, the HA-Bicc1 bpk mutant failed to bind
recombinant GST-SAM fusion protein in pulldown assays (Fig.
4F). HA-Bicc1 bpk also failed to cluster around P-bodies (Fig. 5B)
and to silence the AC6 and PKI 3= UTR luciferase reporters
(Fig. 6C andD). In contrast, mRNAbinding was still detected (see
Fig. S8 in the supplemental material). In proportion to its expres-
FIG 4 Screen for Bicc1 SAM polymer mutants. (A) Bicc1 SAM mutant collection. Shading is as for Fig, 3A. Individual electrostatic patches (patches A to F) at
the protein surface were replaced by alanines. (B, C) Positions of mutations in the Bicc1 SAM dimer model (B) and on the ML surface and EH surface (C). (D)
Table summarizing, for each amino acid patch, the average number of H bonds per time frame during the MD. (E and F) Pulldown of the WT, point mutants,
or 8-fold excess bpkmutant HA-tagged Bicc1 fromHEK293T cell extracts by glutathione-Sepharose beads coated with a recombinant GST control or GST-Bicc1
SAM. Five percent of total cell extracts were loaded as input.
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sion levels, HA-Bicc1 bpk also still inhibited Dvl2 signaling in
TOPflash assays (Fig. 6B and E). Overall, these data show that the
C-terminal elongation of the Bicc1 bpk mutant abrogates SAM
polymerization and mRNA silencing without disrupting the po-
tential to inhibit Dishevelled 2.
To validate a potential influence of the bpkmutation on poly-
meric Bicc1 in vivo, cryosections of kidneys obtained from bpk
mice postnatally were colabeled using anti-Bicc1 antibody and
LTL tomark proximal tubules. Compared to the findings forwild-
type Bicc1, where Bicc1 was concentrated in cytoplasmic foci of
both LTL-positive and LTL-negative renal tubule cells, the cystic
kidneys of bpk mutant animals showed considerably weaker and
more diffuse Bicc1 staining that was confined to LTL-positive
structures (Fig. 7A). This result concurs with the effects of bpk on
Bicc1 protein stability and cytoplasmic clustering observed ex
vivo. However, despite the abnormally diffuse distribution, some
Bicc1 foci remained clearly detectable. To evaluate whether these
residual foci could arise from the alternatively spliced transcript B
that is unaffected by the bpkmutation (17, 22) (see Fig. S1C in the
supplemental material), we overexpressed a synthetic cDNA of
FIG 5 SAMpolymerization is required for Bicc1 clustering. (A) Density fractionation ofWT and polymerizationmutant Bicc1 on a sucrose gradient. HEK293T
cell extracts containing HA-tagged Bicc1 were fractionated on a continuous 15 to 60% sucrose gradient and analyzed by anti-Bicc1 Western blotting. The
migration direction from the top to the bottom of the tube is indicated. RPS6 and 
-tubulin (
-Tub) were used as internal controls. The graph below the gels
shows the percentage of Bicc1 compared to the total Bicc1 signal for each fraction. Results representmean values from 3 independent experiments, and error bars
show SEMs. (B) Bicc1 polymermutants fail to accumulate in cytoplasmic foci. The results of indirect immunofluorescence staining of the HA-Bicc1WT,mutD,
the 	SAMmutant, or the bpkmutant and the P-body marker GFP-Dcp1a overexpressed in COS-1 cells are shown. Bars, 5 m. (C) Comparative 3D rendering
of the HA-Bicc1 WT and mutD by Imaris software. From the original image (center), z-stacks in two directions (z1 and z2, top and right, respectively) and 3D
reconstruction (bottom) are given. Bars, 2 m. (D) Localization by indirect immunofluorescence staining of the Luc-AC6-MS227 reporter mRNA and
HA-Bicc1 in COS-1 cells and comparison with that of HA-Bicc1 mutD. Bars, 5 m.
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this splice variant in transfected cells. Similar to the findings for
full-length Bicc1 encoded by transcript A, transfected isoform B
was readily detected by anti-Bicc1 antibody in cytoplasmic foci,
and it efficiently silenced the Luc-AC6 reporter mRNA (Fig. 7B
and C). It is likely, therefore, that the bpk mutant phenotype is
caused at least in part by the failure of the affected Bicc1 isoformA
to polymerize. In addition, these results are consistent with the
notion that isoform B remains functional and thus likely accounts
for residual hypomorphic Bicc1 activity in bpkmutants. Alterna-
tively, or in addition, cystic growth in bpk mutants may also be
attenuated by polymerization-independent Bicc1 functions, e.g.,
during Wnt signaling.
DISCUSSION
By combining structure modeling and mutagenesis with func-
tional analysis, we identified a self-polymerization interface in the
C-terminal SAM domain of Bicc1 and showed that it stabilizes
full-length Bicc1 in higher-order complexes to regulate its subcel-
lular distribution in the cytoplasm. We provide the first evidence
that Bicc1 also localizes a reporter mRNA that binds the N-termi-
FIG 6 SAM polymerization is required for Bicc1 accumulation and silencing activity. (A) Time course analysis of HA-Bicc1 WT and mutants expressed in
HEK293T cells after CHX treatment. HA-Bicc1 protein levels were compared with 
-tubulin levels by Western blotting at 0, 8, 24, 32, 48, and 56 h. The relative
level of each protein is presented in the graph at the bottom, and the estimated half-life is given on the right. AU, arbitrary units. (B) Level of the HA-Bicc1 WT
andmutants upon transfectionwith a single dose (1) or a double dose (2) ofDNAencodingHA-Bicc1. A double dose of transfectedDNAencodingHA-Bicc1
mutD, the 	SAMmutant, or the bpkmutant is required to obtain a protein level comparable to that of the HA-Bicc1 WT. The relative percentage of WT Bicc1
is indicated for each condition. 
-Tubulin was used for normalization. (C and D) Silencing of AC6 and PKI 3= UTR luciferase reporters by WT or polymer-
ization mutant Bicc1 in HEK293T cells. -Galactosidase was used as a control for normalization. Error bars show SEMs. *, P  0.005. (E) Induction of the
TOPflash reporter of Wnt signaling by Dishevelled 2 (Dvl2) in transfected HEK293T cells is inhibited by both WT and polymerization mutant Bicc1. -Galac-
tosidase was cotransfected for signal normalization. Error bars show SEMs. *, P 0.005.
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nal KH domains and that this process is regulated by SAM clus-
tering. The helical conformation of the polymeric SAM implies
that RNA-binding sites are hyperconcentrated in orderly arrays in
the surrounding space. The loss of SAM polymerization may ex-
plain why the Bicc1 function is impaired in the bpkmouse model
of autosomal recessive polycystic kidney disease. Regulation of
mRNA localization and silencing by SAM polymerization to our
knowledge has not been reported previously.
Structural model of the SAM-SAM interface. SAM domains
are found in many eukaryotic proteins with diverse functions.
Among 72 known human SAM domains that have previously
been analyzed in isolation for their potential to multimerize in
vitro, 47% form polymers (e.g., TEL, Ph, Shank3, DGK1, and
ANKS3), 10% can oligomerize (e.g., ANKS6), and 43% are mo-
nomeric (e.g., Smaug/Vts1p) (42). A purifiedEGFP fusion protein
of the human BICC1 SAM was shown by EM to self-polymerize
(42). Here, EM analysis of an analogous mouse Bicc1 SAM fusion
with GST revealed the presence of similar structures of approxi-
mately 40 nm. Extending this observation, we usedGST pulldown
and sucrose gradient fractionation assays to show that the capacity
to self-interact in higher-order structures is preserved in full-
length Bicc1. The high sequence conservation (31% identity and
54% similarity) between the Bicc1 and DGK1 SAM domains al-
lowed us to derive a homology-based 3D model of dimeric Bicc1
SAM. In this model, the EH surface from one Bicc1 SAM domain
interacts with the ML surface of another through a large electro-
FIG 7 Impaired localization of Bicc1 in bpkmutantmouse kidney. (A) Frozen sections ofWT and bpkmutantmouse kidneys labeled with anti-Bicc1 antibodies
and with the proximal tubule marker LTL on postnatal day 11. Boxed areas are magnified in the panels to the right. Bars, 20 m (large views) and 10 m
(magnified views). (B) Bicc1 isoform B (Bicc1-B) accumulates in cytoplasmic foci. The results of indirect immunofluorescence staining of HA-Bicc1 isoforms A
andB and the P-bodymarkerGFP-Dcp1a in transfectedCOS-1 cells are shown. Bars, 5m. (C) Silencing of AC6 3=UTR luciferase reporter byHA-Bicc1 isoform
A or B in HEK293T cells. -Galactosidase was cotransfected for signal normalization. Error bars show SEMs. *, P 0.005.
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static network that is stabilized by 8 hydrogen bonds during mo-
lecular dynamic simulation and by Phe922 interacting with a hy-
drophobic pocket comprising residues L917, L909, I901, and
F896. Confirming the robustness of our model, alanine scanning
mutagenesis of 6 distinct surface-exposed electrostatic clusters
showed that only the mutations at the predicted SAM-SAM inter-
face impaired polymerization. The determinants mediating this
interaction are conserved in homologous SAM domains, consis-
tent with an important biological function (see Fig. S1D in the
supplemental material).
The SAM domain organizes a helical Bicc1 polymer that is
inhibited by the bpkmutation.Amodel of polymerized Bicc1 via
a SAM-SAM interface built in silico led intrinsically to the forma-
tion of a left-handed head-to-tail helix with 6 SAM units per turn.
Since the N and C termini of each SAM subunit protrude from a
helical polymer toward the periphery, attached domains occupy
the surrounding space in regular arrays (Fig. 3F to I). The putative
RNA-binding GXXG signatures that distinguish the N-terminal
KH fromKH-like domains are thus likely displayed at the periph-
ery and linked to the central SAM scaffold by the intervening
spacer region. This organization suggests that the space near the
center may be too crowded to accommodate bulky additions at
the C terminus or other factors in a polymer. Direct evidence in
support of such a model comes from our analysis of the Bicc1 bpk
mutant, where replacement of the short wild-type C terminus by a
sequence approximately five times larger was sufficient to disrupt
the ability of Bicc1 to self-interact. The simplest possible explana-
tion is that the C-terminal extension of Bicc1bpk sterically hinders
SAM polymerization.
Bicc1 SAM polymerization is not essential to inhibit Dvl ac-
tivity but is necessary to stabilize cytoplasmic foci and to locally
concentrate target mRNA. A previous analysis suggested that a
C-terminal fragment encompassing the SAM domain localizes
Bicc1 in cytoplasmic puncta, but the underlying mechanism re-
mained elusive (35). Here, immunostaining of cryosections re-
vealed that endogenous Bicc1 forms similar clusters in renal tu-
bule cells and in liver cholangiocytes. We propose that clustering
in cytoplasmic foci is mediated by SAM polymerization, since
both the engineered polymerization mutant D and Bicc1bpk were
diffusely distributed in transfected cells compared to the distribu-
tion of wild-type Bicc1. In good agreement with that finding, clus-
tering of Bicc1 in cytoplasmic foci was also impaired in the kidneys
of mice with the bpk mutation in vivo. In addition, failure to po-
lymerize reduced the Bicc1 protein half-life, suggesting that po-
lymerizationmay influence some Bicc1 functions indirectly. Con-
firming this prediction, polymerization-deficient Bicc1	SAM,
Bicc1bpk, and engineered mutant D all inhibited the induction of
the TOPflash reporter by Dvl2 less potently than wild-type Bicc1,
but this defect was rescued when the dosage of mutant proteins
was adapted to restore normal expression levels. Polymeric Bicc1
therefore likely facilitates the inhibition of Dvl2 activity indirectly
by increasing Bicc1 stability.
Our findings show that SAM polymerization also influences
the localization or binding of Bicc1-associated RNAs. Previous
experiments established that Bicc1 coimmunoprecipitates AC6
and PKI mRNAs and specific miRNAs independently of the
SAM domain, whereas deletion of KH domains blocked these in-
teractions (27). In good agreement with those findings, here Bicc1
also bound an AC6-3= UTR luciferase reporter that was tagged
with MS2 hairpins, and this interaction was not overtly altered by
either bpk or the mutation engineered in mutant D or upon dele-
tion of the entire SAM domain. Imaging of the reporter mRNA
using an MS2-YFP fusion protein revealed extensive colocaliza-
tion with wild-type Bicc1 in cytoplasmic foci, whereas in cells
lacking Bicc1, it was diffusely distributed throughout the cyto-
plasm. Interestingly, the reporter mRNA also colocalized with the
engineered SAM polymerization mutant D, albeit it did so dif-
fusely throughout the cytoplasm. We conclude that SAM polym-
erization is not essential for RNA binding but is essential to con-
centrate associated transcripts in cytoplasmic foci.
The SAM-SAM interface is required for silencing of Bicc1
target mRNAs. Previous work established that truncated Bicc1
lacking the SAM domain still binds target mRNAs and miRNAs
yet fails to induce RNA-induced silencing complex loading and
silencing (27). Here, we showed that silencing is also abrogated by
mutations that specifically disrupt the SAM-SAM interface (mu-
tant D) or its potential to polymerize (bpkmutant). These obser-
vations provide strong evidence that the SAM domain promotes
silencing by mediating Bicc1 polymerization. In contrast, polym-
erization was not essential for mRNA binding, indicating that
Bicc1 likely binds target mRNAs before entering polymers. Since
mRNA binding to polymerization-deficient Bicc1 was not suffi-
cient for silencing, the transition to a polymeric configuration
may be the molecular switch that turns off mRNA translation.
Such a model predicts that polymerization is likely regulated. In-
terestingly, a heterozygous mutation in human BICC1 that asso-
ciates with pediatric renal cystic dysplasia replaces the conserved
residue E932 in the SAM domain by glycine. Since E932 is outside
the SAM-SAM interface and dispensable for cytoplasmic cluster-
ing and Bicc1 silencing activity (19), we speculate that it controls
access to a steric inhibitor of Bicc1 polymerization. The extent or
dynamics of SAMpolymerization could also be regulated by other
SAM domain proteins, such as ANKS6. ANKS6 binds and colo-
calizes with Bicc1 (60) and is needed to suppress renal cysts (61,
62). Although ANKS6 was initially considered to self-polymerize
(42), amore recent study showed that it inhibits polymerization of
the related SAM domain protein ANKS3, which can also interact
with Bicc1 (63, 64).
Between the KH domains and SAM, Bicc1 contains an inter-
vening sequence of 461 residues. Interestingly, the homologous
sequence of Xenopus Bic-C is sufficient to mediate translational
repression when tethered as an MS2 fusion protein to a luciferase
reporter mRNA containing MS2 hairpins, and addition of the
SAM domain potentiated this activity (65). In contrast, tethering
of KH or SAM domains alone had no effect. These findings sup-
port our model that SAM primarily serves to cluster and stabilize
Bicc1 in polymers. They also concur with our earlier finding that
mRNA binding to Bicc1 KH domains alone is not sufficient for
translational repression (27). Additional factors may include
miRISC components (27) or binding of unknown factors to the
region between KH and SAM domains, depending on the context
(65). How these or other factors cooperate with SAMpolymeriza-
tion to repress translation will be a fascinating novel area of future
investigation.
How does polymerization influence Bicc1 silencing activity?
One possible mechanism to promote translational repression by
Bicc1 clustering involves the local enrichment of target mRNAs in
microdomains that privilege the access to specific silencing factors
throughmolecular crowding. Crowding influences the thermody-
namic properties of cellular components, and hyperconcentra-
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tion, especially of macromolecules, can alter reaction equilibrium
constants by increasing the probability that substrates will meet
and by decreasing their conformational entropy (66). In a catalytic
model, polymeric Bicc1may thus thermodynamically favor inter-
actions with silencing factors by locally increasing the concentra-
tion of associatedmRNAs and/or by presenting them in an orderly
manner, creating, in effect, a catalytic surface for translational
repression.
An alternative, mutually nonexclusive hypothesis is that Bicc1
acts as an RNA chaperone. A chaperone model takes into account
the structural dimension and striking degree of symmetry of the
Bicc1 polymer. The pitch of helical SAM polymers arranges Bicc1
KH domains such that each individual KH domain n is aligned
with the relatedn 6 domain. Six rows of a givenKHdomain thus
cover the polymer along its length. With 3 KH domains per Bicc1
molecule that can bind RNA, a polymer will present these do-
mains in 18 regularly spaced rows at the surface. Compared to the
binding of monomeric Bicc1, the surface of a polymer is more
likely to bind several RNA molecules simultaneously and/or at
multiple anchoring points and, thus, to favor alternative second-
ary RNA structures that expose or mask specific binding sites of
cognate miRNAs or regulatory proteins. The accessibility of
miRNA seed sequences is essential for silencing and can be regu-
lated by specific RNA-binding proteins, such as Pumilio (67–69).
In a chaperone model, the conformation of an mRNA that is ini-
tially captured by monomeric Bicc1 will change its equilibrium
under the influence of nearby KH domains and possibly other
RNAs on the surface of multimeric Bicc1 after SAM-SAM polym-
erization. The identity of RNA recognition motifs, their number,
and their relative positioning in space could thus govern the si-
lencing by Bicc1 by a complex code.
Our results demonstrate that the SAM domain mediates the
polymerization of full-length Bicc1. We found that this process is
inhibited in the spontaneously mutated Bicc1 bpk allele and
needed to enrich Bicc1 and associatedmRNA in cytoplasmic clus-
ters. SAM-dependent polymerization of the unrelated protein
polyhomeotic-like 2 induces clustering of the polycomb group-
repressive complex 1 on chromatin to repress the transcription of
Hoxb and other target genes (70). SAM-SAM interactions also
control the activity of the transcriptional repressor Yan (71). Ex-
tending this portfolio, our data reveal that SAM domain polym-
erization can also be used by an RNA-binding protein to localize
target mRNAs. This feature might become useful to manipulate
other RNA-binding proteins that normally contain no SAM do-
mains. Further studies and new experimental approaches are also
warranted to further investigate the influence of polymerization
on the spatial positioning of the RNA-binding KH domains or on
the conformation of bound RNAs and its potential regulation by
Bicc1-interacting SAM domain proteins, such as ANKS6 or
ANKS3 (60, 64).
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